SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM S-8
                             REGISTRATION STATEMENT
                        Under The Securities Act of 1933

                      Micro Bio-Medical Waste Systems, Inc.

              Nevada                                    33-0677140
              ------                                    ----------
 (State or other jurisdiction of                      (IRS Employer
  incorporation or organization)                  Identification Number)

             20700 Ventura Blvd. Suite 227, Woodland Hills, CA 91364
--------------------------------------------------------------------------------
               (Address of principal executive offices)(Zip Code)


  Non-Employee Directors, Advisors and Consultants Retainer Stock Plan for 2003
                              (Full Title of Plan)

                             Scott Ervin, President
                              20/20 Networks, Inc.
                          20700 Ventura Blvd. Suite 227
                             Woodland Hills CA 91364
                                 (818) 227-9494
           (Name, address and telephone number of agent for service.)
                                 with copies to:
                                Claudia J. Zaman
                                 Attorney At Law
                          20700 Ventura Blvd. Suite 227
                        Woodland Hills, California 91364

                       CALCULATION OF REGISTRATION FEE

<TABLE>
<CAPTION>
------------------------- ---------------------- ----------------------- ---------------------- ----------------------
Title of Securities to    Proposed Maximum       Proposed Maximum        Amount of Offering     Registration Fee
be Registered             Offering Amount to     Aggregate Price Per     Price
                          be Registered(1)       Unit
------------------------- ---------------------- ----------------------- ---------------------- ----------------------
<S>                       <C>                    <C>                     <C>                    <C>
Common Stock, par value
$.001                     660,000                1.21                    $798,600               $64.61
------------------------- ---------------------- ----------------------- ---------------------- ----------------------
</TABLE>


(1)  This  calculation  is made  solely  for the  purposes  of  determining  the
registration  fee pursuant to the provisions of Rule 457(h) under the Securities
Act and is  calculated  on the basis of the  closing  bid price per share of the
Registrant's common stock on December 15, 2003 as reported by the OTC Electronic
Bulletin Board.



<PAGE>



                                   PROSPECTUS

                      MICRO BIO-MEDICAL WASTE SYSTEMS, INC.
                          20700 Ventura Blvd. Suite 227
                             Woodland Hills CA 91364
                                 (818) 227-9494

                        (660,000 Shares of Common Stock)

This  Prospectus  relates  to the  offer  and  sale by Micro  Bio-Medical  Waste
Systems, Inc. formerly known as 20/20 Networks,  Inc., a Nevada corporation (the
"Company"  or "20/20") of shares of its $.001 par value per share  common  stock
(the "Common Stock") to certain consultants (the "Consultants")  pursuant to the
Company's Non-Employee  Directors,  Advisors and Consultants Retainer Stock Plan
for  2003.  The  Company  is  registering  hereunder  and  then  issuing  to the
Consultants  660,000 shares of Common Stock in consideration  for services to be
performed and for services already performed with the Consultants.

The  Common  Stock  is  not  subject  to  any  restriction  on  transferability.
Recipients  of shares  other than  persons who are  "affiliates"  of the Company
within the  meaning of the  Securities  Act of 1933 (the  "Act") may sell all or
part  of the  shares  in any  way  permitted  by  law,  including  sales  in the
over-the-counter  market  at  prices  prevailing  at the time of such  sale.  An
affiliate is any director,  executive officer or controlling  shareholder of the
Company or any of its subsidiaries.  An "affiliate" of the Company is subject to
Section 16(b) of the Securities  Exchange Act of 1934, as amended (the "Exchange
Act").  If an Employee who is not now an  "affiliate"  becomes an "affiliate" of
the  Company in the  future,  he would  then be subject to Section  16(b) of the
Exchange Act. (See "General Information - Restrictions on Resales").

THESE  SECURITIES  HAVE NOT BEEN APPROVED OR  DISAPPROVED  BY THE SECURITIES AND
EXCHANGE  COMMISSION NOR HAS THE COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY
OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

The date of this Prospectus is December 16, 2003




<PAGE>



This  Prospectus is part of a Registration  Statement which was filed and became
effective under the Securities Act of 1933, as amended (the  "Securities  Act"),
and  does not  contain  all of the  information  set  forth in the  Registration
Statement, certain portions of which have been omitted pursuant to the rules and
regulations  promulgated  by the U.S.  Securities and Exchange  Commission  (the
"Commission")  under the Securities Act. The statements in this Prospectus as to
the contents of any contracts or other  documents  filed as an exhibit to either
the  Registration  Statement or other filings by the Company with the Commission
are qualified in their entirety by the reference thereto.

A copy of any  document  or  part  thereof  incorporated  by  reference  in this
Prospectus  but not  delivered  herewith will be furnished  without  charge upon
written or oral  request.  Requests  should be addressed  to: Micro  Bio-Medical
Waste Systems,  Inc.,  20700 Ventura Blvd.  Suite 227,  Woodland Hills CA 91364,
(818) 227-9494.

The Company is subject to the reporting  requirements of the Exchange Act and in
accordance  therewith files reports and other  information  with the Commission.
These reports, as well as the proxy statements, information statements and other
information  filed by the Company  under the Exchange  Act may be inspected  and
copied at the public  reference  facility  maintained  by the  Commission at 450
Fifth  Street,  N.W.,  Washington,  D.C.  20549.  Copies may be  obtained at the
prescribed rates. The Company's stock is traded on the  over-the-counter  market
and is currently reported by the National  Quotation Bureau Electronic  Bulletin
Board.

No  person  has  been  authorized  to  give  any  information  or  to  make  any
representation,  other than those  contained in this Prospectus and, if given or
made, such other information or representation must not be relied upon as having
been authorized by the Company.  This prospectus does not constitute an offer or
a solicitation by anyone to any person in any state,  territory or possession of
the United States in which such offer or  solicitation  is not authorized by the
laws  thereof,  or to any  person to whom it is  unlawful  to make such offer or
solicitation.

Neither the delivery of this Prospectus or any sale made hereunder shall,  under
any circumstances, create an implication that there has not been a change in the
affairs of the Company since the date hereof.



<PAGE>



                                TABLE OF CONTENTS

Information Required in the Section 10(a) Prospectus                           5
Item 1. Plan Information                                                       5
        General Information                                                    5
        The Company                                                            5
        Purposes                                                               5
        Common Stock                                                           5
        The Consultants                                                        5
        No Restrictions on Transfer                                            5
        Tax Treatment to the Consultants                                       5
        Tax Treatment to the Company                                           6
        Restrictions on Resale                                                 6
Documents Incorporated by Reference and Additional Information                 6
Item 2.  Registrant Information and Employee Plan Annual Information           6
         Legal Opinion and Experts                                             7
         Indemnification of Officers and Directors                             7
Information Required in the Registration Statement                             7
Item 3.  Incorporation of Documents by Reference                               7
Item 4.  Description of Securities                                             8
Item 5.  Interests of Named Experts and Counsel                                8
Item 6.  Indemnification of Directors and Officers                             8
Item 7.  Exemption from Registration Claimed                                   8
Item 8.  Exhibits                                                              9
Item 9.  Undertakings                                                          9
Signatures                                                                    10
Exhibit Index                                                                 12



<PAGE>

                                     PART I

              INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

Item 1.  Plan Information

GENERAL INFORMATION

The Company

The Company has its principal  executive  offices at 20700  Ventura Blvd.  Suite
227, Woodland Hills, CA 91364, where its telephone number is (818) 227-9494.

Purposes

The Company is also issuing shares of its common stocks to certain  non-employee
directors, advisors and consultants for their past services to the Company under
the Company's  Non-Employee  Directors,  Advisors and Consultants Retainer Stock
Plan for 2003 (the "Plan").

Common Stock

The Board of Directors has  authorized  the issuance of up to 660,000  shares of
Common Stock to the  Consultants  and upon  effectiveness  of this  Registration
Statement.

The Consultants

The Consultants have agreed to provide their expertise and advice to the Company
for the purposes set forth in the Plan.

No Restrictions on Transfer

The  Consultants  will become the record and beneficial  owners of the shares of
Common Stock upon issuance and delivery and are entitled to all of the rights of
ownership,  including  the  right  to vote any  shares  awarded  and to  receive
ordinary cash dividends on the Common Stock.

Tax Treatment to the Consultants

The Common Stock is not qualified  under Section 401(a) of the Internal  Revenue
Code.  The  Consultants,  therefore,  will be required  for  federal  income tax
purposes to recognize ordinary income during the taxable year in which the first
of the following events occur: (a) the shares become freely transferable, or (b)
the shares cease to be subject to a substantial risk of forfeiture. Accordingly,
absent a specific  contractual  provision to the contrary,  the Consultants will
receive compensation taxable at ordinary rates equal to the fair market value of
the shares on the date of receipt  since  there will be no  substantial  risk of
forfeiture  or other  restrictions  on transfer.  The  Consultants  are urged to
consult their own tax advisors on this matter.  Further,  if any recipient is an
"affiliate", Section 16(b) of the Exchange Act is applicable and will affect the
issue of taxation.

Tax Treatment to the Company

The amount of income  recognized by any recipient  hereunder in accordance  with
the  foregoing  discussion  will be an expense  deductible  by the  Company  for
federal  income tax purposes in the taxable year of the Company during which the
recipient recognizes income.

Restrictions on Resale



<PAGE>

In the event that an  affiliate of the Company  acquires  shares of Common Stock
hereunder,  the affiliate  will be subject to Section 16(b) of the Exchange Act.
Further,  in the event that any affiliate  acquiring  shares  hereunder  sold or
sells any shares of Common Stock in the six months  preceding  or following  the
receipt of shares  hereunder,  any so called "profit," as computed under Section
16(b) of the Exchange Act,  would be required to be disgorged from the recipient
to the Company.  Services  rendered have been recognized as valid  consideration
for the "purchase" of shares in connection with the "profit"  computation  under
Section  16(b) of the Exchange  Act. The Company has agreed that for the purpose
of any "profit" computation under 16(b), the price paid for the Company's common
stock issued hereunder to affiliates is equal to the value of services rendered.
Shares of the Company's  Common Stock  acquired  hereunder by persons other than
affiliates are not subject to Section 16(b) of the Exchange Act.

                       DOCUMENTS INCORPORATED BY REFERENCE
                                       AND
                             ADDITIONAL INFORMATION

The Company  hereby  incorporates  by reference (1) its Form 10-KSB for the year
ended  December 31, 2002,  filed  pursuant to the Exchange  Act; (2) any and all
Quarterly  Reports  and  Current  Reports  on Form 10-Q (or 10-QSB or 8-K) filed
under the  Securities  Exchange Act  subsequent  to the filing of the  Company's
Annual  Report on Form 10-K (or 10-KSB) for the fiscal year ended  December  31,
2002,  as well as all other  reports filed under Section 13 of the Exchange Act,
and (iii) its annual report, if any, to shareholders  delivered pursuant to Rule
14a-3 of the  Exchange  Act. In  addition,  all further  documents  filed by the
Company  pursuant  to  Section  13,  14, or 15(d) of the  Exchange  Act prior to
termination  of this Offering are deemed to be  incorporated  by reference  into
this  Prospectus  and to be a part  hereof  from  the  date of the  filing.  All
documents which when together constitute this Prospectus,  will be sent or given
to  participants  by the  Registrant  as  specified  by  Rule  428(b)(1)  of the
Securities Act.

Item 2.  Registrant Information and Employee Plan Annual Information

A copy of any  document  or  part  thereof  incorporated  by  reference  in this
Registration  Statement but not delivered  with this  Prospectus or any document
required to be delivered  pursuant to Rule 428(b) under the  Securities Act will
be furnished  without  charge upon written or oral request.  Requests  should be
addressed to: Micro Bio-Medical  Waste Systems,  Inc., 20700 Ventura Blvd. Suite
227, Woodland Hills CA 91364, (818) 227-9494.

Legal Opinion and Experts

Other  than as set  forth  below,  no named  expert  or  counsel  was hired on a
contingent  basis,  will  receive a direct  or  indirect  interest  in the small
business  issuer,  or was a promoter,  underwriter,  voting  trustee,  director,
officer or employee of the Registrant.

The financial  statements of 20/20 Networks,  Inc.  incorporated by reference in
this Prospectus for the fiscal year ended December 31, 2002 have been audited by
Malone &  Bailey,  PLLC,  certified  public  accountants,  as set forth in their
report incorporated herein by reference, and are incorporated herein in reliance
upon such report  given upon the  authority  of said firm as experts in auditing
and accounting.

Indemnification of Officers and Directors


<PAGE>

Insofar as indemnification  for liabilities  arising under the Securities Act of
1933 may be  permitted  to  directors,  officers,  or  persons  controlling  the
Company,  the Company has been informed  that in the opinion of the  Commission,
such indemnification is against public policy as expressed in the Securities Act
and is, therefore,  unenforceable. In the event that a claim for indemnification
against such liabilities  (other than payment by registrant of expenses incurred
or paid by a  director,  officer  or  controlling  person of  registrant  in the
successful  defense of any  action,  suit or  proceeding)  is  asserted  by such
director,  officer or controlling person on connection with the securities being
registered,  registrant  will,  unless in the opinion of its counsel that matter
has been  settled  by  controlling  precedent,  submit  to a court of  competent
jurisdiction  the question of whether  such  indemnification  is against  public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.

                                     PART II

                             INFORMATION REQUIRED IN
                           THE REGISTRATION STATEMENT

Item 3.  Incorporation of Documents by Reference

Registrant  hereby  states that (i) all  documents set forth in (a) through (c),
below, are incorporated by reference in this  registration  statement,  and (ii)
all documents subsequently filed by registrant pursuant to Section 13(a), 13(c),
14 and 15(d) of the  Securities  Exchange Act of 1934, as amended,  prior to the
filing of a post-effective amendment which indicates that all securities offered
have been sold or which de-registers all securities then remaining unsold, shall
be deemed to be incorporated by reference in this registration  statement and to
be a part hereof from the date of filing of such documents.

(a) Registrant's latest Annual Report, whether filed pursuant to Section 13(a)or
15(d) of the Exchange Act;

(b) All other reports  filed  pursuant to Section 13(a) or 15(d) of the Exchange
Act since the end of the fiscal year covered by the annual report referred to in
(a) above; and

(c) The latest  prospectus  filed  pursuant to Rule 424(b) under the  Securities
Act.

Item 4.  Description of Securities

No  description  of the class of  securities  (i.e.,  the $.001 par value common
stock) is required under this item because the Common Stock is registered  under
Section 12 of the Exchange Act.

Item 5.  Interests of Named Experts and Counsel

Ms. Zaman owns shares of the Company's  common stock but is not being issued any
of the shares which are being registered hereunder.

Item 6.  Indemnification of Directors and Officers

The Company  shall  indemnify  to the fullest  extent  permitted  by, and in the
manner  permissible  under the laws of the State of Nevada,  any person made, or
threatened  to be made, a party to an action or  proceeding,  whether  criminal,
civil, administrative or investigative,  by reason of the fact that he is or was
a  director  or  officer  of the  Company,  or served  any other  enterprise  as
director,  officer  or  employee  at the  request of the  Company.  The Board of
Directors,  in its discretion,  shall have the power on behalf of the Company to
indemnify  any person,  other than a director  or  officer,  made a party to any
action,  suit or  proceeding  by  reason  of the fact  that  he/she is or was an
employee of the Company.


<PAGE>

Pursuant to the Company's bylaws, the Company shall have the right to indemnify,
to  purchase  indemnity  insurance  for,  and to pay and  advance  expenses  to,
Directors, Officers and other persons who are eligible for, or entitled to, such
indemnification,  payments or advances,  in  accordance  with and subject to the
provisions of Nevada Corporation Law and any amendments  thereto,  to the extent
such indemnification, payments or advances are either expressly required by such
provisions  or are  expressly  authorized  by the Board of Directors  within the
scope of such  provisions.  The right of the Company to  indemnify  such persons
shall include, but not be limited to, the authority of the Company to enter into
written agreements for indemnification with such persons.

Subject to the provisions of Nevada Revised Statutes and any amendments thereto,
a Director  of the  Corporation  shall not be liable to the  Corporation  or its
shareholders  for  monetary  damages for an act or  omission  in the  Director's
capacity as a Director,  except that this  provision does not eliminate or limit
the liability of a Director to the extent the Director is found liable for:

1) a  breach  of the  Director's  duty  of  loyalty  to the  Corporation  or its
shareholders;

2) an act or omission not in good faith that constitutes a breach of duty of the
Director to the  Corporation  or an act or omission  that  involves  intentional
misconduct or a knowing  violation of the law;

3) A transaction from which the Director received an improper  benefit,  whether
or not the  benefit  resulted  from an  action  taken  within  the  scope of the
Director's office; or

4) an act or  omission  for which  the  liability  of a  Director  is  expressly
provided by an applicable statute.

Item 7.  Exemption from Registration Claimed

         Not Applicable.

Item 8.  Exhibits

(a) The  following  exhibits  are filed as part of this  registration  statement
pursuant to Item 601 of Regulation S-B and are specifically  incorporated herein
by this reference:

Exhibit No.    Title
-----------    -----

5              Opinion  of  Claudia  J.  Zaman  regarding  the  legality  of the
               securities registered.

10.8*          20/20  Networks,  Inc.  Non-Employee   Directors,   Advisors  and
               Consultants Retainer Stock Plan for 2003

23.1           Consent of Claudia J. Zaman,  counsel to the  registrant,  to the
               use of her opinion with respect to the legality of the securities
               being  registered  hereby  and  to the  references  to her in the
               Prospects filed as part hereof.

23.2           Consent  of  Malone-Bailey,  PLLC,  independent  auditors  of the
               registrant



<PAGE>

         Item 9.  Undertakings

         Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors,  officers and controlling  persons of
the registrant pursuant to the foregoing  provisions  otherwise,  the registrant
has been advised that in the opinion of the Securities and Exchange  Commission,
such  indemnification  is against  public policy as expressed in the Act and is,
therefore,  unenforceable. In the event that a claim for indemnification against
such liabilities  (other than the payment by the registrant of expenses incurred
or paid by a director,  officer or  controlling  person of the registrant in the
successful  defense of any  action,  suit or  proceeding)  is  asserted  by such
director,  officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter
has been  settled by  controlling  precedent,  submit to a court of  appropriate
jurisdiction the question whether such  indemnification  by it is against public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.

         Registrant hereby undertakes:

(1) To file,  during  any  period in which  offers or sales  are being  made,  a
post-effective amendment to this Registration Statement:

         (i) To include  any  prospectus  required  by Section  10(a)(3)  of the
Securities Act of 1933;

         (ii) To reflect in the prospectus any facts or events arising after the
effective date of the Registration  Statement (or the most recent post-effective
amendment  thereof)  which,  individually  or  in  the  aggregate,  represent  a
fundamental change in the information set forth in the Registration Statement;

         (iii) To include any material  information  with respect to the plan of
distribution  not  previously  disclosed  in the  registration  statement or any
material change to such information in the registration statement;

                  provided,  however, paragraphs (i) and (ii) shall not apply if
the information  required to be included in a post-effective  amendment by those
paragraphs  are  incorporated  by reference  from periodic  reports filed by the
registrant small business issuer under the Exchange Act.

(2) That, for the purpose of determining  any liability under the Securities Act
of  1933,  each  such  post-effective  amendment  shall  be  deemed  to be a new
registration  statement  relating to the  securities  offered  therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

(3) To remove from  registration by means of a  post-effective  amendment any of
the securities  being  registered  which remain unsold at the termination of the
offering.

(4) to deliver or cause to be delivered with the  prospectus,  to each person to
whom the  prospectus  is sent or given,  the latest  annual  report to  security
holders  that is  incorporated  by  reference in the  prospectus  and  furnished
pursuant  to and  meeting  the  requirements  of Rule  14a-3 or 14e-3  under the
Securities  Exchange  Act of  1934;  and  where  interim  financial  information
required to be presented by Article 3 of Regulation  S-X is not set forth in the
prospectus,  to deliver,  or cause to be  delivered,  to each person to whom the
prospectus is sent or given,  the latest  quarterly  report that is specifically
incorporated  by reference in the  prospectus to provide such interim  financial
information.


<PAGE>

Registrant  hereby  undertakes  that, for purposes of determining  any liability
under the Securities Act of 1933, each filing of the Registrant's  annual report
pursuant to Section  13(a) of the  Securities  Exchange Act of 1934 (and,  where
applicable,  each filing of an employee benefit's plan annual report pursuant to
Section 15(d) of the Securities  Exchange Act of 1934) that is  incorporated  by
reference in the registration statement shall be deemed to be a new registration
statement relating to the securities  offered therein,  and the offering of such
securities  at that time shall be deemed to be the  initial  bona fide  offering
thereof.

                                   SIGNATURES

Pursuant to the  requirements  of the  Securities  Act of 1933,  the  Registrant
certifies  that it has  reasonable  grounds  to  believe  that it meets  all the
requirements  for  filing  on Form S-8 and has  duly  caused  this  registration
statement  to be  signed  on  its  behalf  by  the  undersigned  thereunto  duly
authorized in the City of Woodland Hills, California on December 16, 2003.

                                Micro Bio-Medical Waste Systems, Inc.

                                By: /s/ Scott A. Ervin
                                    -------------------------------------
                                    Scott A. Ervin, President

                                By: /s/ Charles Smith
                                    -------------------------------------
                                    Charles Smith, CFO

In  accordance  with  the  requirements  of the  Securities  Act of  1933,  this
registration statement was signed by the following persons in the capacities and
on the dates stated:

December 16, 2003                   /s/ Charles  Smith
                                    -------------------------------------
                                    Charles Smith, Director

December 16, 2003                   /s/ Steven Onoue
                                    -------------------------------------
                                    Steven Y. Onoue, Director


                                    -------------------------------------
December 16, 2003                   Merhrdad Alborz, Director


<PAGE>



                         FORM S-8 REGISTRATION STATEMENT

                                  EXHIBIT INDEX

         The following exhibits are filed as part of this registration statement
pursuant to Item 601 of Regulation S-B and are specifically  incorporated herein
by this reference:

<TABLE>
<CAPTION>
Exhibit Number in
Registration                                                                            Numbered
Statement                               Description                                        Page
---------                               -----------                                        ----
<S>            <C>                                                                 <C>
5.             Opinion of Counsel

10.8*          Non-Employee  Directors,  Advisors and Consultants Retainer Stock
               Plan for 2003

23.2           Consent of Claudia J. Zaman to Use of Opinion

23.1           Consent of Malone-Bailey, PLLC
</TABLE>



---------------
* previously filed
[{"type": "S-8", "sequence": "1", "filename": "forms8.txt", "secsgml_size_bytes": 28775}]
{"company-data": {"conformed-name": "20/20 NETWORKS INC", "cik": "0001103833", "assigned-sic": "9995", "irs-number": "330677140", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "S-8", "act": "33", "file-number": "333-111394", "film-number": "031065640"}, "business-address": {"street1": "20700 VENTURA BLVD.", "street2": "SUITE 227", "city": "WOODLAND HILLS", "state": "CA", "zip": "91364", "phone": "818227-9494"}, "mail-address": {"street1": "20700 VENTURA BLVD.", "street2": "SUITE 227", "city": "WOODLANDS HILLS", "state": "CA", "zip": "91364"}}
SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM S-8
                             REGISTRATION STATEMENT
                        Under The Securities Act of 1933

                      Micro Bio-Medical Waste Systems, Inc.

              Nevada                                    33-0677140
              ------                                    ----------
 (State or other jurisdiction of                      (IRS Employer
  incorporation or organization)                  Identification Number)

             20700 Ventura Blvd. Suite 227, Woodland Hills, CA 91364
--------------------------------------------------------------------------------
               (Address of principal executive offices)(Zip Code)

  Non-Employee Directors, Advisors and Consultants Retainer Stock Plan for 2003
                              (Full Title of Plan)

                             Scott Ervin, President
                              20/20 Networks, Inc.
                          20700 Ventura Blvd. Suite 227
                             Woodland Hills CA 91364
                                 (818) 227-9494
           (Name, address and telephone number of agent for service.)
                                 with copies to:
                                Claudia J. Zaman
                                 Attorney At Law
                          20700 Ventura Blvd. Suite 227
                        Woodland Hills, California 91364

                       CALCULATION OF REGISTRATION FEE
------------------------- ---------------------- ----------------------- ---------------------- ----------------------
Title of Securities to    Proposed Maximum       Proposed Maximum        Amount of Offering     Registration Fee
be Registered             Offering Amount to     Aggregate Price Per     Price
                          be Registered(1)       Unit
------------------------- ---------------------- ----------------------- ---------------------- ----------------------
Common Stock, par value
$.001                     660,000                1.21                    $798,600               $64.61
------------------------- ---------------------- ----------------------- ---------------------- ----------------------
(1)  This  calculation  is made  solely  for the  purposes  of  determining  the
registration  fee pursuant to the provisions of Rule 457(h) under the Securities
Act and is  calculated  on the basis of the  closing  bid price per share of the
Registrant's common stock on December 15, 2003 as reported by the OTC Electronic
Bulletin Board.
PROSPECTUS

                      MICRO BIO-MEDICAL WASTE SYSTEMS, INC.
                          20700 Ventura Blvd. Suite 227
                             Woodland Hills CA 91364
                                 (818) 227-9494

                        (660,000 Shares of Common Stock)

This  Prospectus  relates  to the  offer  and  sale by Micro  Bio-Medical  Waste
Systems, Inc. formerly known as 20/20 Networks,  Inc., a Nevada corporation (the
"Company"  or "20/20") of shares of its $.001 par value per share  common  stock
(the "Common Stock") to certain consultants (the "Consultants")  pursuant to the
Company's Non-Employee  Directors,  Advisors and Consultants Retainer Stock Plan
for  2003.  The  Company  is  registering  hereunder  and  then  issuing  to the
Consultants  660,000 shares of Common Stock in consideration  for services to be
performed and for services already performed with the Consultants.

The  Common  Stock  is  not  subject  to  any  restriction  on  transferability.
Recipients  of shares  other than  persons who are  "affiliates"  of the Company
within the  meaning of the  Securities  Act of 1933 (the  "Act") may sell all or
part  of the  shares  in any  way  permitted  by  law,  including  sales  in the
over-the-counter  market  at  prices  prevailing  at the time of such  sale.  An
affiliate is any director,  executive officer or controlling  shareholder of the
Company or any of its subsidiaries.  An "affiliate" of the Company is subject to
Section 16(b) of the Securities  Exchange Act of 1934, as amended (the "Exchange
Act").  If an Employee who is not now an  "affiliate"  becomes an "affiliate" of
the  Company in the  future,  he would  then be subject to Section  16(b) of the
Exchange Act. (See "General Information - Restrictions on Resales").

THESE  SECURITIES  HAVE NOT BEEN APPROVED OR  DISAPPROVED  BY THE SECURITIES AND
EXCHANGE  COMMISSION NOR HAS THE COMMISSION PASSED UPON THE ACCURACY OR ADEQUACY
OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.

The date of this Prospectus is December 16, 2003
This  Prospectus is part of a Registration  Statement which was filed and became
effective under the Securities Act of 1933, as amended (the  "Securities  Act"),
and  does not  contain  all of the  information  set  forth in the  Registration
Statement, certain portions of which have been omitted pursuant to the rules and
regulations  promulgated  by the U.S.  Securities and Exchange  Commission  (the
"Commission")  under the Securities Act. The statements in this Prospectus as to
the contents of any contracts or other  documents  filed as an exhibit to either
the  Registration  Statement or other filings by the Company with the Commission
are qualified in their entirety by the reference thereto.

A copy of any  document  or  part  thereof  incorporated  by  reference  in this
Prospectus  but not  delivered  herewith will be furnished  without  charge upon
written or oral  request.  Requests  should be addressed  to: Micro  Bio-Medical
Waste Systems,  Inc.,  20700 Ventura Blvd.  Suite 227,  Woodland Hills CA 91364,
(818) 227-9494.

The Company is subject to the reporting  requirements of the Exchange Act and in
accordance  therewith files reports and other  information  with the Commission.
These reports, as well as the proxy statements, information statements and other
information  filed by the Company  under the Exchange  Act may be inspected  and
copied at the public  reference  facility  maintained  by the  Commission at 450
Fifth  Street,  N.W.,  Washington,  D.C.  20549.  Copies may be  obtained at the
prescribed rates. The Company's stock is traded on the  over-the-counter  market
and is currently reported by the National  Quotation Bureau Electronic  Bulletin
Board.

No  person  has  been  authorized  to  give  any  information  or  to  make  any
representation,  other than those  contained in this Prospectus and, if given or
made, such other information or representation must not be relied upon as having
been authorized by the Company.  This prospectus does not constitute an offer or
a solicitation by anyone to any person in any state,  territory or possession of
the United States in which such offer or  solicitation  is not authorized by the
laws  thereof,  or to any  person to whom it is  unlawful  to make such offer or
solicitation.

Neither the delivery of this Prospectus or any sale made hereunder shall,  under
any circumstances, create an implication that there has not been a change in the
affairs of the Company since the date hereof.
TABLE OF CONTENTS

Information Required in the Section 10(a) Prospectus                           5
Item 1. Plan Information                                                       5
        General Information                                                    5
        The Company                                                            5
        Purposes                                                               5
        Common Stock                                                           5
        The Consultants                                                        5
        No Restrictions on Transfer                                            5
        Tax Treatment to the Consultants                                       5
        Tax Treatment to the Company                                           6
        Restrictions on Resale                                                 6
Documents Incorporated by Reference and Additional Information                 6
Item 2.  Registrant Information and Employee Plan Annual Information           6
         Legal Opinion and Experts                                             7
         Indemnification of Officers and Directors                             7
Information Required in the Registration Statement                             7
Item 3.  Incorporation of Documents by Reference                               7
Item 4.  Description of Securities                                             8
Item 5.  Interests of Named Experts and Counsel                                8
Item 6.  Indemnification of Directors and Officers                             8
Item 7.  Exemption from Registration Claimed                                   8
Item 8.  Exhibits                                                              9
Item 9.  Undertakings                                                          9
Signatures                                                                    10
Exhibit Index                                                                 12
PART I

              INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS

Item 1.  Plan Information

GENERAL INFORMATION

The Company

The Company has its principal  executive  offices at 20700  Ventura Blvd.  Suite
227, Woodland Hills, CA 91364, where its telephone number is (818) 227-9494.

Purposes

The Company is also issuing shares of its common stocks to certain  non-employee
directors, advisors and consultants for their past services to the Company under
the Company's  Non-Employee  Directors,  Advisors and Consultants Retainer Stock
Plan for 2003 (the "Plan").

Common Stock

The Board of Directors has  authorized  the issuance of up to 660,000  shares of
Common Stock to the  Consultants  and upon  effectiveness  of this  Registration
Statement.

The Consultants

The Consultants have agreed to provide their expertise and advice to the Company
for the purposes set forth in the Plan.

No Restrictions on Transfer

The  Consultants  will become the record and beneficial  owners of the shares of
Common Stock upon issuance and delivery and are entitled to all of the rights of
ownership,  including  the  right  to vote any  shares  awarded  and to  receive
ordinary cash dividends on the Common Stock.

Tax Treatment to the Consultants

The Common Stock is not qualified  under Section 401(a) of the Internal  Revenue
Code.  The  Consultants,  therefore,  will be required  for  federal  income tax
purposes to recognize ordinary income during the taxable year in which the first
of the following events occur: (a) the shares become freely transferable, or (b)
the shares cease to be subject to a substantial risk of forfeiture. Accordingly,
absent a specific  contractual  provision to the contrary,  the Consultants will
receive compensation taxable at ordinary rates equal to the fair market value of
the shares on the date of receipt  since  there will be no  substantial  risk of
forfeiture  or other  restrictions  on transfer.  The  Consultants  are urged to
consult their own tax advisors on this matter.  Further,  if any recipient is an
"affiliate", Section 16(b) of the Exchange Act is applicable and will affect the
issue of taxation.

Tax Treatment to the Company

The amount of income  recognized by any recipient  hereunder in accordance  with
the  foregoing  discussion  will be an expense  deductible  by the  Company  for
federal  income tax purposes in the taxable year of the Company during which the
recipient recognizes income.

Restrictions on Resale
In the event that an  affiliate of the Company  acquires  shares of Common Stock
hereunder,  the affiliate  will be subject to Section 16(b) of the Exchange Act.
Further,  in the event that any affiliate  acquiring  shares  hereunder  sold or
sells any shares of Common Stock in the six months  preceding  or following  the
receipt of shares  hereunder,  any so called "profit," as computed under Section
16(b) of the Exchange Act,  would be required to be disgorged from the recipient
to the Company.  Services  rendered have been recognized as valid  consideration
for the "purchase" of shares in connection with the "profit"  computation  under
Section  16(b) of the Exchange  Act. The Company has agreed that for the purpose
of any "profit" computation under 16(b), the price paid for the Company's common
stock issued hereunder to affiliates is equal to the value of services rendered.
Shares of the Company's  Common Stock  acquired  hereunder by persons other than
affiliates are not subject to Section 16(b) of the Exchange Act.

                       DOCUMENTS INCORPORATED BY REFERENCE
                                       AND
                             ADDITIONAL INFORMATION

The Company  hereby  incorporates  by reference (1) its Form 10-KSB for the year
ended  December 31, 2002,  filed  pursuant to the Exchange  Act; (2) any and all
Quarterly  Reports  and  Current  Reports  on Form 10-Q (or 10-QSB or 8-K) filed
under the  Securities  Exchange Act  subsequent  to the filing of the  Company's
Annual  Report on Form 10-K (or 10-KSB) for the fiscal year ended  December  31,
2002,  as well as all other  reports filed under Section 13 of the Exchange Act,
and (iii) its annual report, if any, to shareholders  delivered pursuant to Rule
14a-3 of the  Exchange  Act. In  addition,  all further  documents  filed by the
Company  pursuant  to  Section  13,  14, or 15(d) of the  Exchange  Act prior to
termination  of this Offering are deemed to be  incorporated  by reference  into
this  Prospectus  and to be a part  hereof  from  the  date of the  filing.  All
documents which when together constitute this Prospectus,  will be sent or given
to  participants  by the  Registrant  as  specified  by  Rule  428(b)(1)  of the
Securities Act.

Item 2.  Registrant Information and Employee Plan Annual Information

A copy of any  document  or  part  thereof  incorporated  by  reference  in this
Registration  Statement but not delivered  with this  Prospectus or any document
required to be delivered  pursuant to Rule 428(b) under the  Securities Act will
be furnished  without  charge upon written or oral request.  Requests  should be
addressed to: Micro Bio-Medical  Waste Systems,  Inc., 20700 Ventura Blvd. Suite
227, Woodland Hills CA 91364, (818) 227-9494.

Legal Opinion and Experts

Other  than as set  forth  below,  no named  expert  or  counsel  was hired on a
contingent  basis,  will  receive a direct  or  indirect  interest  in the small
business  issuer,  or was a promoter,  underwriter,  voting  trustee,  director,
officer or employee of the Registrant.

The financial  statements of 20/20 Networks,  Inc.  incorporated by reference in
this Prospectus for the fiscal year ended December 31, 2002 have been audited by
Malone &  Bailey,  PLLC,  certified  public  accountants,  as set forth in their
report incorporated herein by reference, and are incorporated herein in reliance
upon such report  given upon the  authority  of said firm as experts in auditing
and accounting.

Indemnification of Officers and Directors
Insofar as indemnification  for liabilities  arising under the Securities Act of
1933 may be  permitted  to  directors,  officers,  or  persons  controlling  the
Company,  the Company has been informed  that in the opinion of the  Commission,
such indemnification is against public policy as expressed in the Securities Act
and is, therefore,  unenforceable. In the event that a claim for indemnification
against such liabilities  (other than payment by registrant of expenses incurred
or paid by a  director,  officer  or  controlling  person of  registrant  in the
successful  defense of any  action,  suit or  proceeding)  is  asserted  by such
director,  officer or controlling person on connection with the securities being
registered,  registrant  will,  unless in the opinion of its counsel that matter
has been  settled  by  controlling  precedent,  submit  to a court of  competent
jurisdiction  the question of whether  such  indemnification  is against  public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.

                                     PART II

                             INFORMATION REQUIRED IN
                           THE REGISTRATION STATEMENT

Item 3.  Incorporation of Documents by Reference

Registrant  hereby  states that (i) all  documents set forth in (a) through (c),
below, are incorporated by reference in this  registration  statement,  and (ii)
all documents subsequently filed by registrant pursuant to Section 13(a), 13(c),
14 and 15(d) of the  Securities  Exchange Act of 1934, as amended,  prior to the
filing of a post-effective amendment which indicates that all securities offered
have been sold or which de-registers all securities then remaining unsold, shall
be deemed to be incorporated by reference in this registration  statement and to
be a part hereof from the date of filing of such documents.

(a) Registrant's latest Annual Report, whether filed pursuant to Section 13(a)or
15(d) of the Exchange Act;

(b) All other reports  filed  pursuant to Section 13(a) or 15(d) of the Exchange
Act since the end of the fiscal year covered by the annual report referred to in
(a) above; and

(c) The latest  prospectus  filed  pursuant to Rule 424(b) under the  Securities
Act.

Item 4.  Description of Securities

No  description  of the class of  securities  (i.e.,  the $.001 par value common
stock) is required under this item because the Common Stock is registered  under
Section 12 of the Exchange Act.

Item 5.  Interests of Named Experts and Counsel

Ms. Zaman owns shares of the Company's  common stock but is not being issued any
of the shares which are being registered hereunder.

Item 6.  Indemnification of Directors and Officers

The Company  shall  indemnify  to the fullest  extent  permitted  by, and in the
manner  permissible  under the laws of the State of Nevada,  any person made, or
threatened  to be made, a party to an action or  proceeding,  whether  criminal,
civil, administrative or investigative,  by reason of the fact that he is or was
a  director  or  officer  of the  Company,  or served  any other  enterprise  as
director,  officer  or  employee  at the  request of the  Company.  The Board of
Directors,  in its discretion,  shall have the power on behalf of the Company to
indemnify  any person,  other than a director  or  officer,  made a party to any
action,  suit or  proceeding  by  reason  of the fact  that  he/she is or was an
employee of the Company.
Pursuant to the Company's bylaws, the Company shall have the right to indemnify,
to  purchase  indemnity  insurance  for,  and to pay and  advance  expenses  to,
Directors, Officers and other persons who are eligible for, or entitled to, such
indemnification,  payments or advances,  in  accordance  with and subject to the
provisions of Nevada Corporation Law and any amendments  thereto,  to the extent
such indemnification, payments or advances are either expressly required by such
provisions  or are  expressly  authorized  by the Board of Directors  within the
scope of such  provisions.  The right of the Company to  indemnify  such persons
shall include, but not be limited to, the authority of the Company to enter into
written agreements for indemnification with such persons.

Subject to the provisions of Nevada Revised Statutes and any amendments thereto,
a Director  of the  Corporation  shall not be liable to the  Corporation  or its
shareholders  for  monetary  damages for an act or  omission  in the  Director's
capacity as a Director,  except that this  provision does not eliminate or limit
the liability of a Director to the extent the Director is found liable for:

1) a  breach  of the  Director's  duty  of  loyalty  to the  Corporation  or its
shareholders;

2) an act or omission not in good faith that constitutes a breach of duty of the
Director to the  Corporation  or an act or omission  that  involves  intentional
misconduct or a knowing  violation of the law;

3) A transaction from which the Director received an improper  benefit,  whether
or not the  benefit  resulted  from an  action  taken  within  the  scope of the
Director's office; or

4) an act or  omission  for which  the  liability  of a  Director  is  expressly
provided by an applicable statute.

Item 7.  Exemption from Registration Claimed

         Not Applicable.

Item 8.  Exhibits

(a) The  following  exhibits  are filed as part of this  registration  statement
pursuant to Item 601 of Regulation S-B and are specifically  incorporated herein
by this reference:

Exhibit No.    Title
-----------    -----

5              Opinion  of  Claudia  J.  Zaman  regarding  the  legality  of the
               securities registered.

10.8*          20/20  Networks,  Inc.  Non-Employee   Directors,   Advisors  and
               Consultants Retainer Stock Plan for 2003

23.1           Consent of Claudia J. Zaman,  counsel to the  registrant,  to the
               use of her opinion with respect to the legality of the securities
               being  registered  hereby  and  to the  references  to her in the
               Prospects filed as part hereof.

23.2           Consent  of  Malone-Bailey,  PLLC,  independent  auditors  of the
               registrant
Item 9.  Undertakings

         Insofar as indemnification for liabilities arising under the Securities
Act of 1933 may be permitted to directors,  officers and controlling  persons of
the registrant pursuant to the foregoing  provisions  otherwise,  the registrant
has been advised that in the opinion of the Securities and Exchange  Commission,
such  indemnification  is against  public policy as expressed in the Act and is,
therefore,  unenforceable. In the event that a claim for indemnification against
such liabilities  (other than the payment by the registrant of expenses incurred
or paid by a director,  officer or  controlling  person of the registrant in the
successful  defense of any  action,  suit or  proceeding)  is  asserted  by such
director,  officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter
has been  settled by  controlling  precedent,  submit to a court of  appropriate
jurisdiction the question whether such  indemnification  by it is against public
policy as expressed in the Act and will be governed by the final adjudication of
such issue.

         Registrant hereby undertakes:

(1) To file,  during  any  period in which  offers or sales  are being  made,  a
post-effective amendment to this Registration Statement:

         (i) To include  any  prospectus  required  by Section  10(a)(3)  of the
Securities Act of 1933;

         (ii) To reflect in the prospectus any facts or events arising after the
effective date of the Registration  Statement (or the most recent post-effective
amendment  thereof)  which,  individually  or  in  the  aggregate,  represent  a
fundamental change in the information set forth in the Registration Statement;

         (iii) To include any material  information  with respect to the plan of
distribution  not  previously  disclosed  in the  registration  statement or any
material change to such information in the registration statement;

                  provided,  however, paragraphs (i) and (ii) shall not apply if
the information  required to be included in a post-effective  amendment by those
paragraphs  are  incorporated  by reference  from periodic  reports filed by the
registrant small business issuer under the Exchange Act.

(2) That, for the purpose of determining  any liability under the Securities Act
of  1933,  each  such  post-effective  amendment  shall  be  deemed  to be a new
registration  statement  relating to the  securities  offered  therein,  and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

(3) To remove from  registration by means of a  post-effective  amendment any of
the securities  being  registered  which remain unsold at the termination of the
offering.

(4) to deliver or cause to be delivered with the  prospectus,  to each person to
whom the  prospectus  is sent or given,  the latest  annual  report to  security
holders  that is  incorporated  by  reference in the  prospectus  and  furnished
pursuant  to and  meeting  the  requirements  of Rule  14a-3 or 14e-3  under the
Securities  Exchange  Act of  1934;  and  where  interim  financial  information
required to be presented by Article 3 of Regulation  S-X is not set forth in the
prospectus,  to deliver,  or cause to be  delivered,  to each person to whom the
prospectus is sent or given,  the latest  quarterly  report that is specifically
incorporated  by reference in the  prospectus to provide such interim  financial
information.
Registrant  hereby  undertakes  that, for purposes of determining  any liability
under the Securities Act of 1933, each filing of the Registrant's  annual report
pursuant to Section  13(a) of the  Securities  Exchange Act of 1934 (and,  where
applicable,  each filing of an employee benefit's plan annual report pursuant to
Section 15(d) of the Securities  Exchange Act of 1934) that is  incorporated  by
reference in the registration statement shall be deemed to be a new registration
statement relating to the securities  offered therein,  and the offering of such
securities  at that time shall be deemed to be the  initial  bona fide  offering
thereof.

                                   SIGNATURES

Pursuant to the  requirements  of the  Securities  Act of 1933,  the  Registrant
certifies  that it has  reasonable  grounds  to  believe  that it meets  all the
requirements  for  filing  on Form S-8 and has  duly  caused  this  registration
statement  to be  signed  on  its  behalf  by  the  undersigned  thereunto  duly
authorized in the City of Woodland Hills, California on December 16, 2003.

                                Micro Bio-Medical Waste Systems, Inc.

                                By: /s/ Scott A. Ervin
                                    -------------------------------------
                                    Scott A. Ervin, President

                                By: /s/ Charles Smith
                                    -------------------------------------
                                    Charles Smith, CFO

In  accordance  with  the  requirements  of the  Securities  Act of  1933,  this
registration statement was signed by the following persons in the capacities and
on the dates stated:

December 16, 2003                   /s/ Charles  Smith
                                    -------------------------------------
                                    Charles Smith, Director

December 16, 2003                   /s/ Steven Onoue
                                    -------------------------------------
                                    Steven Y. Onoue, Director

                                    -------------------------------------
December 16, 2003                   Merhrdad Alborz, Director
FORM S-8 REGISTRATION STATEMENT

                                  EXHIBIT INDEX

         The following exhibits are filed as part of this registration statement
pursuant to Item 601 of Regulation S-B and are specifically  incorporated herein
by this reference:
Exhibit Number in
Registration                                                                            Numbered
Statement                               Description                                        Page
---------                               -----------                                        ----
5.             Opinion of Counsel

10.8*          Non-Employee  Directors,  Advisors and Consultants Retainer Stock
               Plan for 2003

23.2           Consent of Claudia J. Zaman to Use of Opinion

23.1           Consent of Malone-Bailey, PLLC
---------------
* previously filed